Rivian Revises 2025 Delivery Targets Amid New Tariffs

Published 14 hours agoRIVN

Rivian Revises 2025 Delivery Targets Amid New Tariffs

Rivian has revised its delivery projections for 2025 due to the impact of new U.S. tariffs on vehicle imports. The electric vehicle maker now expects to deliver between 40,000 and 46,000 vehicles, down from its earlier estimate of 46,000 to 51,000. This adjustment is primarily in response to increased production costs brought about by the tariffs, which affect imported battery cells and other components, potentially raising vehicle costs by several thousand dollars per unit, according to Reuters.

The company has also increased its capital expenditure forecast for the year to approximately $1.8 billion to $1.9 billion, up from the previous range of $1.6 billion to $1.7 billion. A portion of this increase includes a $120 million investment in a new supplier park near Rivian's Illinois manufacturing plant, aimed at reducing logistical expenses and supporting the company's operational needs with the approaching launch of the R2 SUV.

Rivian's strategic moves come in the wake of these challenging new trade policies and include a planned production pause later this year to retool its assembly lines for the R2 SUV, which is slated for an early 2026 launch. The R2 is a mid-size all-electric SUV set to retail at about $45,000, designed to offer a more accessible vehicle option and planned for international sales, including in Europe.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Shift4 Payments Extends Offer to Acquire Global Blue in $2.5 Billion Deal

Shift4 Payments Extends Offer to Acquire Global Blue in $2.5 Billion Deal

6 minutes agoFOUR

Shift4 Payments has announced an extension to its tender offer to acquire Global Blue, a prominent provider of tax-free shopping and currency conversion services, particularly for luxury brands. The proposed acquisition price is $7.50 per common share, which is a 15% premium over Global Blue's closing share price as of February 14, 2025. The deal values the transaction at approximately $2.5 billion. Shift4's acquisition aims to boost its unified commerce capabilities and facilitate expansion into over 400,000 retail and hospitality locations using Global Blue's technology. Backing the acquisition are notable shareholders such as Ant International and Tencent, who together hold about 90% of Global Blue's common and preferred shares. Reuters reported that the financial arrangement involves Shift4 using its cash reserves along with a $1.795 billion bridge loan. The acquisition is anticipated to be finalized by the third quarter of 2025, pending regulatory and traditional closing conditions. This strategic move is expected to enhance Shift4's presence and capabilities within the global commerce payment landscape, leveraging Global Blue's specialized solutions.

Novo Nordisk Lowers 2025 Forecasts Amid Wegovy Sales Drop

Novo Nordisk Lowers 2025 Forecasts Amid Wegovy Sales Drop

21 minutes agoNVO

Novo Nordisk has adjusted its financial outlook for 2025 following a decline in the U.S. prescriptions for its weight-loss drug, Wegovy. The Danish pharmaceutical giant has reduced its sales and profit projections due to a notable decrease in demand for Wegovy and Ozempic in the U.S. market. This decision comes in light of rising challenges within the obesity drug sector. The Financial Times highlighted these changes, attributing part of the drop to pharmacy-created compounded versions of the drugs, especially during periods of supply shortages. In the first quarter, Wegovy sales fell 13% from the previous quarter to 17.36 billion Danish crowns, which translates to approximately $2.64 billion. This was below analyst expectations, which were set at 18.7 billion crowns. Reuters reported that these figures, along with the competitive pressure from Eli Lilly's Zepbound, which has overtaken Wegovy in U.S. prescriptions, have impacted Novo Nordisk's standing in the market. In response to these challenges, Novo Nordisk is strategizing to recapture its market share in the latter half of the year. The company plans to increase its sales efforts via partnerships with CVS and telehealth providers and further expand Wegovy's availability across 25 international markets. This is part of a broader attempt to revive branded sales and strengthen its position amidst the competitive landscape.

Google Embraces Nuclear Energy to Power AI Data Centers

Google Embraces Nuclear Energy to Power AI Data Centers

36 minutes agoGOOGL

Google is making strides in securing sustainable energy resources by turning to nuclear power to address the rising energy demands of its data centers, intensified by the growing use of AI applications. The tech giant has entered into a partnership with Kairos Power, signing a deal in October 2024 to acquire energy from small modular reactors (SMRs). This will enable Google to equip its data centers with a reliable, low-carbon power source, with the initial reactor set to be operational by 2030 and additional units expected by 2035, collectively generating 500 megawatts of power, as reported by The Guardian. This development is part of Google's broader strategy to explore different energy solutions while maintaining its commitment to net-zero emissions, according to Business Insider. CEO Sundar Pichai has noted that SMRs are among the various technologies under consideration to meet the company's significant energy needs. Google's approach aligns with a larger industry trend where companies such as Amazon and Microsoft are also investing in nuclear energy for their data centers to cope with AI-driven electricity consumption, highlighted by AP News. The shift towards nuclear energy is driven by the substantial increase in energy requirements due to AI advancements. A single inquiry to AI models like ChatGPT reportedly consumes almost tenfold the electricity of a typical Google search, underlining the need for sustainable power solutions. These strategic initiatives reflect Google's commitment to environmental sustainability while ensuring it can support the energy needs of its advanced AI operations.

CVS Health Stock Rises Post-Earnings and Outlook Upgrade

CVS Health Stock Rises Post-Earnings and Outlook Upgrade

51 minutes agoCVS

CVS Health has seen a significant rise in stock price following the release of its recent earnings report. In the first quarter of 2025, the company reported an adjusted earnings per share of $2.25, beating analyst projections of $1.70. This better-than-expected performance was largely driven by enhanced Medicare benefits and higher ratings for its Medicare Advantage plans, boosting investor confidence. AP News highlighted these positive results as a key driver of the stock's upward movement. Beyond earnings, CVS Health reported a 7% increase in revenue, reaching $94.59 billion and exceeding previous analyst expectations. This growth was mainly attributed to strong performances in the Health Services and Pharmacy & Consumer Wellness segments. Following these results, the company's stock rose by over 8% in premarket trading, indicating strong market approval. Reinforcing this positive momentum, CVS Health upgraded its full-year adjusted EPS forecast to a range of $6.00 to $6.20. This revision reflects confidence in the company's direction under CEO David Joyner, who has been leading cost-cutting and management restructuring efforts since October 2024. Reuters reported that these initiatives aim to enhance operational efficiency and maximize shareholder value, suggesting a promising future for the company.